|
KB408 (Nebulization) Clinical Trials
1 actively recruiting trial across 1 location
Gainesville, Florida1 trial
A Study of KB408 for the Treatment of Alpha-1 Antitrypsin Deficiency
University of Florida, Gainesville
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.